A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Duodenitis

Clinical trial NCT04856891 · COMPLETED

Trial details

NCT number: NCT04856891
Sponsor: Allakos Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Eosinophilic Duodenitis Eosinophilic Gastroenteritis

Start date: 2021-05-20
Primary completion: 2022-06-14
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.